Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Symptomatic management in multiple sclerosis].

A Pappalardo1, F Patti, D A Restivo

  • 1Sezione Sclerosi Multipla e Malattie Demielinizzanti, Università degli Studi di Catania, Italia. pange.bel@virgilio.it

La Clinica Terapeutica
|May 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing proximity care for people with multiple sclerosis in Italy: the bottom-up approach of the StayHome project.

Journal of neurology·2025
Same author

Direct Observation of Competing M1 and M3 Transitions in ^{10}B.

Physical review letters·2024
Same author

Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina.

European review for medical and pharmacological sciences·2024
Same author

Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.

Journal of neurology·2024
Same author

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal of medical economics·2023
Same author

Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors.

Multiple sclerosis and related disorders·2023

Multiple sclerosis (MS) is an autoimmune CNS disorder affecting millions globally. This review covers diagnostic, prognostic, and therapeutic strategies, emphasizing symptomatic treatments for broad patient benefit.

Area of Science:

  • Neurology
  • Immunology
  • Neuroscience

Context:

  • Multiple sclerosis (MS) is a chronic autoimmune disease targeting the Central Nervous System (CNS).
  • Etiology remains unknown, impacting approximately 2 million people worldwide, predominantly in North America and Northern Europe.
  • Current management involves immunomodulatory therapies and symptomatic treatments.

Purpose:

  • To review current medical options for the diagnosis of MS.
  • To discuss prognostic indicators and therapeutic strategies for MS management.
  • To provide a comprehensive overview of managing MS, including disease-modifying and symptomatic approaches.

Summary:

  • The review details diagnostic criteria and prognostic factors for multiple sclerosis.
  • It examines immunomodulatory treatments and highlights the universal benefit of symptomatic therapies for MS patients.

Related Experiment Videos

  • The authors present a consolidated view of medical interventions in MS care.

    • Impact:

    • Enhances understanding of MS management options for healthcare professionals.
    • Aids in optimizing patient care by outlining diagnostic, prognostic, and therapeutic pathways.
    • Contributes to the body of knowledge on multiple sclerosis, informing clinical practice and future research.